Guardant Health
GH
#1548
Rank
HK$103.63 B
Marketcap
HK$797.96
Share price
-1.56%
Change (1 day)
182.01%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -HK$25.02

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$24.98. In 2024 the company made an earnings per share (EPS) of -HK$27.70 an increase over its 2023 EPS that were of -HK$33.30.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$25.02-9.7%
2024-HK$27.70-16.82%
2023-HK$33.30-33.13%
2022-HK$49.8060%
2021-HK$31.1355.04%
2020-HK$20.08207.14%
2019-HK$6.54-19.81%
2018-HK$8.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-HK$16.65-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-HK$37.41 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA